jopatclo wrote: Interesting positif the vulture GranhamB mec no shares Ventripoint . See before no sales & now ( It will be interesting to see if they have been able to get any sales....there been essentially no sales )
-CardioLogic Ltd Introducing Ventripoint 4.0! Ventripoint is a groundbreaking cardiac imaging tool that converts echo images into accurate volumes and ejection fractions for all four heart chambers, delivering results with the accuracy of cardiac MRI.
With its new capabilities, Ventripoint 4.0 provides additional insights, including:
-3D Tensors: Visualise the direction and magnitude of surface changes.
-4D Motion: Simulate a dynamic heart model across the cardiac cycle.
-3D Global Strain: Assess longitudinal, circumferential, and total surface area changes.
-3D Heat Map: Visualise surface area changes in a new heat map view.
-3D Segmentation: Access a detailed polar map for surface area change analysis.
- Now That V4.0 Europe V4.0 ok & Canada -The BEST automation and analysis of the PLANET GEN3EHO
https://ascendcv.com/ (Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients.)
- I think they know more about the Ventripoint tech than the whiners on this board. Something could happen anytime real fast!
FDA 4.0 It will happen, but not in a way we originally hoped. No investor is happy with the current outcome. You either wait or move on.
- Dr. Adams is a visionary with Ventripoint FDA V4.0 and Sales at any time now Insiders know!
https://ascendcv.com/ #vpt, and Remember Clik integrations and see
Seamless, flexible integration with heterogeneous AI, imaging and enterprise IT environments enables a best-of breed approach. Examples include: - Us2.ai - Benefit from the the industry’s most sophisticated integration of Us2.ai.
- Us2.ai FDA-approved measurements feed ASE-validated suggested interpretations that can automatically complete the echo report
- Save time with single-click navigation to the automated measurement source frame
- 1-click sync to automated measurement frame
- Distinct review processes for FDA-cleared versus investigational measurements, enhancing compliance and clarity
- Automatic grouping of Us2.ai measurements accelerates the measurement review process
- Visual notification of user edits performed on Us2.ai measurements promotes transparency and traceability
- Engineered for seamless integration: Gen3Echo was designed with commitment to openness, seamlessly integrating with AI, ML, and advanced visualization software to foster innovation and collaboration.
- Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients. Ventripoint’s VMS product is powered by its proprietary KBR technology and provides accurate volumetric cardiac measurements with sMRI levels of accuracy. It can be used with all ultrasound systems supported by regulatory market approvals and is seamlessly integrated into the reading workflow enhancing diagnostic precision and treatment planning, ultimately improving the quality of pediatric care.